Caffeic acid phenethyl ester decreases the level of S-100B protein after middle cerebral after occlusion in rabbits
dc.authorscopusid | 15823044400 | |
dc.authorscopusid | 7004686098 | |
dc.authorscopusid | 19933417600 | |
dc.authorscopusid | 19933866500 | |
dc.authorscopusid | 8944423300 | |
dc.contributor.author | Serarslan, Yurdal | |
dc.contributor.author | Bal, Ramazan | |
dc.contributor.author | Altu?, Muhammed Enes | |
dc.contributor.author | Kontaş, Tünay | |
dc.contributor.author | Melek, Ismet Murat | |
dc.date.accessioned | 2024-09-19T15:45:21Z | |
dc.date.available | 2024-09-19T15:45:21Z | |
dc.date.issued | 2009 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | Effects of caffeic acid phenethyl ester (CAPE) on the serum S-100B levels were studied as an index for brain damage after permanent middle cerebral artery (MCA) occlusion in rabbits. Twenty rabbits were divided into four groups (n=5): control, sham, non-treatment and CAPE. The right MCA was occluded using a microsurgical procedure with bipolar coagulation and was then transected in non-treatment and CAPE groups. The rabbits in the sham group underwent a surgical procedure but the MCA was not occluded. No surgery was performed in the control group. CAPE was administered after MCA occlusion at the dose of 10?g/kg, once a day intraperitoneally for 7 days in the CAPE group. Serum S-100B levels were determined on days 1, 2, 4 and 7. Serum S-100B level was significantly increased following permanent MCA occlusion. Posttreatment of CAPE significantly reduced the serum S-100B level. This study demonstrated that CAPE is capable of attenuating increased serum S-100B level induced by MCA occlusion in rabbits. CAPE may be useful as a neuroprotective agent. | en_US |
dc.identifier.endpage | 316 | en_US |
dc.identifier.issn | 1011-601X | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 19553181 | en_US |
dc.identifier.scopus | 2-s2.0-68549110519 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 313 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/14608 | |
dc.identifier.volume | 22 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Pakistan Journal of Pharmaceutical Sciences | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Brain | en_US |
dc.subject | Caffeic acid phenethyl ester | en_US |
dc.subject | CAPE | en_US |
dc.subject | Experimental stroke | en_US |
dc.subject | MCA | en_US |
dc.subject | Middle cerebral artery occlusion | en_US |
dc.subject | S100B | en_US |
dc.title | Caffeic acid phenethyl ester decreases the level of S-100B protein after middle cerebral after occlusion in rabbits | en_US |
dc.type | Article | en_US |